Treventis

Early APOE4 effects may begin with disruptions in hippocampal circuit stability, long before Alzheimer’s symptoms appear.

In young APOE4 knockin mice, researchers recently identified region-specific network hyperexcitability that later predicted cognitive decline. This abnormal activity arose from distinct groups of smaller, overactive neurons and disappeared when APOE4 was selectively removed from neurons, pointing to a direct neuronal role for the risk gene. As the mice aged, the dentate gyrus developed granule cell hyperexcitability, weakened inhibition, and an excitation-inhibition imbalance. Single-nucleus RNA sequencing revealed age- and cell-type-specific gene changes, including Nell2 as a potential driver of early excitability. CRISPR interference targeting Nell2 normalized abnormal neuronal activity, linking this molecule to APOE4-related dysfunction. These findings connect APOE4 to early circuit impairment and suggest new molecular targets for preventing AD progression.

Visit us at https://treventis.com/


https://www.nature.com/articles/s43587-026-01096-0

A brief cellular encounter with toxic tau oligomers may trigger a long-lasting cascade of synaptic damage tied to Alzheimer’s disease.

In human iPSC-derived neurons, researchers tracked postsynaptic protein changes minutes after exposure and found an early loss of actin motor proteins needed for AMPA receptor movement and synaptic plasticity. Within 24 hours, disease-associated proteins such as GSK3β increased at postsynaptic sites. Over the following days, postsynaptic structures declined first, followed later by presynaptic terminal loss. This stepwise pattern suggests that early postsynaptic disruption may be a trigger for broader synaptic failure over time. Even surviving synapses remained impaired, showing weaker AMPA receptor signaling, fewer vesicle clusters, and lower neurotransmitter release.

The study outlines two harmful outcomes: some synapses progressively weaken, while others disappear entirely, offering a clearer timeline of how tau drives bipartite synapse failure in dementia.

Visit us at https://treventis.com/


https://link.springer.com/article/10.1186/s13024-026-00928-2

A genome-wide CRISPRi screen in human iPSC-derived neurons has identified key regulators of tau buildup, offering new insights into why some neurons are more vulnerable in tauopathies like Alzheimer’s disease and FTD.

The study uncovered both expected and unexpected pathways, including UFMylation and GPI anchor biosynthesis, which are important in controlling tau oligomer levels. Researchers also found that the E3 ubiquitin ligase complex CRL5SOCS4 helps regulate tau turnover by marking tau for degradation, with higher levels linked to resistance in human tauopathy cases. This explains how failures in protein quality control can lead to selective neuronal vulnerability. Additionally, mitochondrial dysfunction has been shown to promote abnormal tau processing through reactive oxygen species, resulting in disease-associated tau fragments that encourage aggregation.

These findings expand our understanding of tau proteostasis, highlighting promising targets for slowing neurodegeneration.

Visit us at https://treventis.com/


https://www.cell.com/cell/fulltext/S0092-8674(25)01487-4?_returnURL=https%3A%2F%2Flinkinghub.elsevier.com%2Fretrieve%2Fpii%2FS0092867425014874%3Fshowall%3Dtrue

Beginning cognitive stimulation before amyloid buildup may help strengthen brain resilience in Alzheimer’s disease (AD) patients.

In TgF344-AD rat models, long-term training preserved memory and maintained connectivity between the entorhinal cortex and dentate gyrus, with the clearest benefits observed in male transgenic animals. Researchers also found restored synaptic plasticity markers, sex-specific molecular responses, as well as reduced inhibitory signaling in trained male rat models. At earlier stages, stimulation briefly improved microglial behavior around amyloid plaques, suggesting a temporary boost in the brain’s ability to respond to the pathology. These findings indicate that timing is important, with earlier intervention offering a better chance to protect vulnerable neural networks. These results support the idea that cognitive reserve can delay functional decline. The study also shows that males and females may benefit through different biological mechanisms.

Visit us at https://treventis.com/


https://www.cell.com/iscience/fulltext/S2589-0042(25)02642-2?_returnURL=https%3A%2F%2Flinkinghub.elsevier.com%2Fretrieve%2Fpii%2FS2589004225026422%3Fshowall%3Dtrue